Unknown

Dataset Information

0

Antagonism/Agonism modulation to build novel antihypertensives selectively triggering i1-imidazoline receptor activation.


ABSTRACT: Pharmacological studies have suggested that I1-imidazoline receptors are involved in the regulation of cardiovascular function and that selective I1-agonists, devoid of the side effects associated with the common hypotensive ?2-adrenoreceptor agonists, might be considered as a second generation of centrally acting antihypertensives. Therefore, in the present study, inspired by the antihypertensive behavior of our selective I1-agonist 4, we designed, prepared, and studied the novel analogues 5-9. A selective I1-profile, associated with significant hemodinamic effects, was displayed by 5, 8, and 9. Interestingly, the highest potency and longest lasting activity displayed by 8 (carbomethyline) suggested that van der Waals interactions, promoted by the ortho methyl decoration of its aromatic moiety, are particularly advantageous. In addition, in analogy to what was noted for (S)-(+)-4, the observation that only (S)-(+)-8 displayed significant hemodynamic effects unequivocally confirmed the stereospecific nature of the I1 proteins.

SUBMITTER: Del Bello F 

PROVIDER: S-EPMC4434467 | biostudies-literature | 2015 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Antagonism/Agonism modulation to build novel antihypertensives selectively triggering i1-imidazoline receptor activation.

Del Bello Fabio F   Bargelli Valentina V   Cifani Carlo C   Gratteri Paola P   Bazzicalupi Carla C   Diamanti Eleonora E   Giannella Mario M   Mammoli Valerio V   Matucci Rosanna R   Micioni Di Bonaventura Maria Vittoria MV   Piergentili Alessandro A   Quaglia Wilma W   Pigini Maria M  

ACS medicinal chemistry letters 20150403 5


Pharmacological studies have suggested that I1-imidazoline receptors are involved in the regulation of cardiovascular function and that selective I1-agonists, devoid of the side effects associated with the common hypotensive α2-adrenoreceptor agonists, might be considered as a second generation of centrally acting antihypertensives. Therefore, in the present study, inspired by the antihypertensive behavior of our selective I1-agonist 4, we designed, prepared, and studied the novel analogues 5-9.  ...[more]

Similar Datasets

| S-EPMC3306695 | biostudies-literature
| S-EPMC3531387 | biostudies-literature
| S-EPMC6703385 | biostudies-literature
| S-EPMC6107436 | biostudies-literature
| S-EPMC1574957 | biostudies-other
| S-EPMC4983495 | biostudies-literature
| S-EPMC4392396 | biostudies-literature
2023-12-21 | GSE251794 | GEO
| S-EPMC2922134 | biostudies-literature